Novo Nordisk Files Lawsuits Against Pharmacies for Selling Tainted Knockoff Drugs

Novo Nordisk has filed lawsuits against two compounding pharmacies in Florida, accusing them of selling impure and potentially unsafe knockoff versions of its weight loss drug Wegovy and diabetes medication Ozempic. The Danish drugmaker found that the products from Wells Pharmacy Network and Brooksville Pharmaceuticals contained unknown and unauthorized substances, posing safety risks to consumers. Novo Nordisk is seeking to bar the pharmacies from selling their products and has filed a total of 12 legal actions against compounding pharmacies allegedly selling dupes of Wegovy and Ozempic. Rival Eli Lilly has taken similar action against businesses selling knockoffs of its diabetes drug Mounjaro.